For the Win: Cerave Scores Big with SuperBowl Ad
For weeks, actor Michael Cera has been in the news and across social media promoting his ‘namesake’ brand, CeraVe. In the new ad, Cera goes toe-to-toe with dermatologists and reveals his very own Michael CeraVe commercial, but Cera’s bizarre campaign gets debunked by a boardroom of CeraVe dermatologists, who reminded him that CeraVe is and always has […]
On the Horizon: New, Non-invasive Light-based Techniques May Help Detect Skin Cancer in Older Adults
When examined under polarized laser light, ageing skin looks noticeably different than younger skin, and this finding could pave the way for new, non-invasive light-based techniques to detect skin cancer in older individuals. The new study indicates that the altered light scattering properties of ageing skin are largely due to changes in the skin’s texture, […]
Get to Know Alys Pharmaceuticals, Inc.
Alys Pharmaceuticals, Inc. is coming out of the gate strong with $100M financing from Medicxi to advance its immuno-dermatology focused pipeline. Alys combines six asset-centric Medicxi companies including Al Aldena Therapeutics, Graegis Pharmaceuticals, Granular Therapeutics, Klirna Biotech, Nira Biosciences and Vimela Therapeutics. Co-founded by Medicxi and several dermatology and scientific experts, including TDD Editorial Advisory Board member John […]
“Comforting and Encouraging” Study Shows JAK Inhibitors Not Linked to Short-Term Heart Woes in Derm Patients
By Ted Rosen, MD According to the results of a recently published investigation in JAMA Dermatology1, the Janus kinase (JAK) inhibitors currently utilized for a variety of skin diseases appear safe in our dermatological population. A meta-analysis of 45 randomized clinical trials comprised of 12,996 patients disclosed neither an increased risk of major cardiovascular events (MACE) such as […]
One-on-One: TDD Talks to Leo Pharma’s Brian Hilberdink About Chronic Hand Eczema and the Delta Force Trial
Leo Pharma recently reported that delgocitinib cream, an investigational topical pan-JAK inhibitor, demonstrated a superior reduction in Hand Eczema Severity Index (HECSI) score from baseline to Week 12 compared to alitretinoin capsules in people with severe chronic hand eczema (CHE) in the DELTA FORCE Trial, which is the first head-to-head phase 3 trial comparing a […]
AAAAI News: Early Skin Microbiome and Metabolome Signatures May Predict AD in Infants
Early skin microbiome and metabolome signatures can predict atopic dermatitis in infants aged 6 to 18 months old, according to new research being presented at the 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting. The Singapore Preconception Study of Long-Term Maternal and Child Outcomes (S-PRESTO) mother-offspring cohort profiled bacterial metagenomics, antimicrobial peptides (AMPs) […]
Behind the Scenes: Cetaphil Rolls Out New Super Bowl-inspired Campaign
For some the Super Bowl is all about the big game, for others it’s the half-time show and for others still, it’s the commercials. And Cetaphil will be launching a new campaign in advance of the Super Bowl that was inspired by Gen Z’s growing interest in skincare and football. Taylor Swift and her association with the National […]
Cutera Begins AviClear Roll Out in the U.K., Europe, and Australia
Cutera announced the international limited commercial release of AviClear, a 1726nm laser which targets and suppresses the production of sebum to treat acne at its source. The company announced the limited release at the International Master Course on Aging Science (IMCAS) conference in Paris, France. AviClear is now commercially available, on a limited basis, in the […]
Galderma Takes the ‘Face of Cetaphil’ to New York Fashion Week
Cetaphil’s New York Fashion Week activation enlists influencers and consumers from 14 different countries to be the ‘Face of Cetaphil’ as an extension of the brand’s ‘We Do Skin, You Do You’ campaign, Participants will have entered a global contest to win a trip to New York City, where they will act as on-the-ground correspondents alongside other […]
Oh, The Places Dermatology Will Go in 2024!
In 2023, dermatologists and their patients welcomed new drugs for acne, psoriasis, alopecia areata, and more, and 2024 promises to deliver real-world data on these medications along with even more therapeutic innovations across the spectrum of cutaneous diseases. The Dermatology Digest asked key thought leaders and editorial advisory board members to take out their crystal balls and […]